Back

American Association for the Study of Liver Diseases

  • Carcinoma, Hepatocellular
  • Hemorrhage
  • Hypertension, Portal
  • Varicose Veins

Management of Portal Hypertension in Patients with HCC

Management of Portal Hypertension in patients with HCC is very challenging. There are several areas that remain controversial including bleeding risk from gastroesophageal varices in the setting of systemic therapy with Anti-VEGF based combinations for HCC. The optimal management strategy in such patients requires a multidisciplinary approach. Additionally, among patients with HCC presenting with variceal bleeding, the role of TPC to manage variceal bleeding event and prevent future bleeding during the HCC treatment is unclear. Careful selection of potential candidates is key in these complicated situations. This webinar is intended to provide a framework and answer commonly encountered questions in the scenarios based on available evidence. This webinar is intended for gastroenterologists, hepatologists, fellows, trainees and nurse practitioners. Others with an interest in management of portal hypertension are invited to attend.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Blended / Other
  • Credit · Up to 1 credit
  • Released
    Jul 28, 2026
  • Last day to claim credit
    Jul 29, 2027 10 months left